sulfasalazine has been researched along with Autoimmune Demyelinating Disease, Peripheral in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Excerpt | Relevance | Reference |
---|---|---|
"The neurological manifestations of Crohn's disease are rare, dominated by multiple mononeuropathies and the abnormalities of the white matter." | 1.34 | [Crohn's disease presenting with recurrent acute polyradiculoneuropathy]. ( El Moutawakil, B; Gam, I; Rafai, MA; Rhimou, A; Slassi, I; Tahiri, JM, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El Moutawakil, B | 1 |
Rafai, MA | 1 |
Gam, I | 1 |
Tahiri, JM | 1 |
Rhimou, A | 1 |
Slassi, I | 1 |
1 other study available for sulfasalazine and Autoimmune Demyelinating Disease, Peripheral
Article | Year |
---|---|
[Crohn's disease presenting with recurrent acute polyradiculoneuropathy].
Topics: Adult; Anti-Inflammatory Agents; Budesonide; Combined Modality Therapy; Crohn Disease; Diarrhea; Dru | 2007 |